Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Add a Comment By Jim Stallard, MA, Writer/Editor   |  Wednesday, March 20, 2013 Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

See more here:
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Share and Enjoy:
  • Print
  • Digg
  • StumbleUpon
  • Facebook
  • Yahoo! Buzz
  • Twitter
  • Google Bookmarks
  • Add to favorites
  • email
  • LinkedIn
  • RSS
  • Tumblr
Share